(Q73825935)

English

Analysis of the eligibility of published economic evaluations for transfer to a given health care system. Methodological approach and application to the French health care system

scientific article published on 01 November 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Analysis of the eligibility of published economic evaluations for transfer to a given health care system. Methodological approach and application to the French health care system (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

H M Späth

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M O Carrère

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

B Fervers

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Philip

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 November 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

49

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

161-177

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

An exercise on the feasibility of carrying out secondary economic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The status of health technology assessment worldwide. Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic analyses of clinical trials in cancer: are they helpful to policy makers?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation alongside cancer trials: methodological and practical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Is Helicobacter pylori eradication a cost-effective treatment of duodenal ulcer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Issues in the cross-national assessment of health technology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of cost-effectiveness analyses of hypertension treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The generalisability of pharmacoeconomic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

European School of Oncology Advisory report to the Commission of the European Communities for the "Europe Against Cancer Programme" cost-effectiveness in cancer care.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpreting cost analyses of clinical interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of age on cost-effectiveness ratios and its control in decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The distinction between cost and charges

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic therapy in breast cancer: efficacy and cost utility

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating treatment cost functions for progressive diseases: a multiproduct approach with an application to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The costs of treating breast cancer in Australia and the implications for breast cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Should women with node-negative breast cancer receive adjuvant chemotherapy?--Insights from a decision analysis model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the cost effectiveness of adjuvant therapies in early breast cancer using a decision analysis model.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Does the breast cancer dollar make sense?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The social, emotional and financial implications of adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant therapy of node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating the treatment costs of breast and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of hospital services by breast cancer patients by stage of the disease: implications on the costs of cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Current and future costs of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness in oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment costs of adjuvant cytotoxic therapy in premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation of mental health care interventions. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality assessment of pharmacoeconomic abstracts of original research articles in selected journals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Extrapolation of cost-effectiveness information to local settings

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900057-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8510(99)00057-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10827295%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73825935&oldid=2034217444"